
Home
Chapter Home
Jobs
Conferences
Fellowships
Books
Advertisement
Bladder
Other tumors
Lymphoma (primary)
Reviewers: Gillian Levy, M.D., Yale Medical Center (see Reviewers page)
Revised: 24 April 2011, last major update April 2011
Copyright: (c) 2003-2011, PathologyOutlines.com, Inc.
Definition
=========================================================================
● Either primary (rare, originating in bladder with no known lymphoma elsewhere) or secondary (much more common)
Epidemiology
=========================================================================
● Female predominance, most cases are in middle aged women
● Secondary bladder involvement occurs in 10-25% of leukemias / lymphomas and in advanced stage systemic lymphoma
● Rare as primary; <100 cases
● MALT is most common subtype in bladder; typically affects adults > 60 years, 75% female
● Diffuse large B cell lymphoma is also common, and may arise from transformation of MALT (J Clin Pathol 2000;53:458)
Sites
=========================================================================
● Bladder, lower ureteral tract
Clinical features
=========================================================================
● Comprises 5% of non-urothelial tumors of urothelial tract
● Long median survival for either primary lymphoma of bladder or lymphoma with initial presentation in bladder but other coexisting disease (Am J Surg Pathol 1997;21:1324)
● Recurrent lymphoma in bladder is associated with widely disseminated disease and poor prognosis
● Presents with gross hematruia, dysuria, urinary frequency, nocturia, and abdominal or back pain
● Low grade MALT lymphoma: most common lymphoma subtype in bladder; much more common as secondary tumor than primary tumor; history of chronic cystitis common (Arch Pathol Lab Med 2001;125:332)
Prognostic factors
=========================================================================
● Histologic subtype, stage
Case reports
=========================================================================
● 52 year old man with schistosomiasis and T cell lymphoma (Am J Surg Pathol 1998;22:373)
● 67 year old woman with EBV+ B cell lymphoproliferative disorder (Indian J Urol 2009;25:129)
● 72 year old woman with exophytic mass at bladder base and MALT lymphoma (Mod Pathol 1993;6:145)
● 75 year old woman with diffuse large B cell lymphoma (Intern Med 2009;48:1403)
● Elderly woman with B cell lymphoma with signet-ring cells (Arch Pathol Lab Med 1991;115:635)
Treatment
=========================================================================
● MALT: radiation therapy, usually no recurrences
Radiological imaging
=========================================================================
● Submucosal masses: 70% of cases are solitary mass, 20% of cases are multiple masses, and 10% of cases show diffuse wall thickening
Gross description (Macroscopy)
=========================================================================
● Discrete tumors, usually large and centered in dome or lateral walls
Micro description (Histopathology)
=========================================================================
● MALT: sheets of low grade, uniform cells that surround and separate, but don’t destroy muscle fascicles
Micro images
=========================================================================
MALT:
Tumor cells separate and surround rather than destroy the smooth muscle fascicles of the bladder wall

Bland lymphocytes fill lamina propria but don’t involve urothelium

Lymphocytes permeate muscle fascicles

Monocytoid cells with clear cytoplasm

Fig 1: MALT involving lamina propria; fig 2: focal lymphoepithelial lesions in area of cystitis glandularis
EBV+ B cell lymphoproliferative disorder:

Left: diffuse infiltrate of atypical lymphocytes; right: CD20+

Left: CD30+; right: EBER+
Cytology description
=========================================================================
● MALT: monomorphic small to medium sized lymphocytes
Positive stains
=========================================================================
● Varies by subtype of lymphoma; B cell lymphomas are CD20+
● MALT lymphoma: CD20+, CD19+, CD5-, CD23-, CD10-, CD11c-, FMC7+
Negative stains
=========================================================================
● Pan-keratin, vimentin, CK20, CK7
Molecular/cytogenetics description
=========================================================================
● MALT Lymphoma: t(11;18) (q21:21)
Differential diagnosis
=========================================================================
● Urothelial carcinoma with prominent lymphoid infiltrate: see
Am J Surg Pathol 1991;15:569
● Undifferentiated carcinoma
End of Bladder > Other tumors > Lymphoma
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com
with any questions (click here for other
contact information).